Effect of shRNA targeting survivin on ovarian cancer (Q39377771)

11 September 2017

title

Effect of shRNA targeting survivin on ovarian cancer (English)

1 reference

11 September 2017

Jun Xing

1

1 reference

11 September 2017

Chang-Ru Jia

2

1 reference

11 September 2017

Yan Wang

3

1 reference

11 September 2017

Jing Guo

4

1 reference

11 September 2017

Yan Cai

5

1 reference

11 September 2017

publication date

18 March 2012

1 reference

Journal of Cancer Research and Clinical Oncology

11 September 2017

published in

1 reference

11 September 2017

volume

138

1 reference

11 September 2017

issue

7

1 reference

11 September 2017

page(s)

1221-1229

1 reference

Survivin and IAP proteins in cell-death mechanisms

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Survivin as a cell cycle-related and antiapoptotic protein in granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Matrix metalloproteinases and their inhibitors in tumour growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Survivin knockdown combined with apoptin overexpression inhibits cell growth significantly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

The collagenase gene family in humans consists of at least four members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Matrix metalloproteinases: biologic activity and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

RNA interference in the clinic: challenges and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Matrix metalloproteinases: effectors of development and normal physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Cancer cells survive with survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1196-0

[The significance of metalloproteinases and their inhibitors in gastric cancer]

21 January 2018

1 reference

12 December 2020

Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer

1 reference

12 December 2020

Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma

1 reference

12 December 2020

Short hairpin RNA targeting survivin inhibits growth and angiogenesis of glioma U251 cells

1 reference

12 December 2020

Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors

1 reference

12 December 2020

RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM

1 reference

12 December 2020

Studies on Multifunctional Effect of All-Trans Retinoic Acid (ATRA) on Matrix Metalloproteinase-2 (MMP-2) and Its Regulatory Molecules in Human Breast Cancer Cells (MCF-7).

1 reference

12 December 2020

Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer

1 reference

12 December 2020

[Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP].

1 reference

12 December 2020

Down-regulation of survivin and hypoxia-inducible factor-1 α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft

1 reference

12 December 2020

[Effect of RNAi-mediated survivin gene silencing on apoptosis of ovarian cancer cell lines SKOV3 and SKOV3/ADM]

1 reference

12 December 2020

10.1007/S00432-012-1196-0

Identifiers

DOI

1 reference

11 September 2017

1 reference